T45.1 - Poisoning by, adverse effect of and underdosing of antineoplastic and immunosuppressive drugs
The ICD 10 Code for
Poisoning by, adverse effect of and underdosing of antineoplastic and immunosuppressive drugs is listed as
T45.1. Additional information concerning this code and description can be found below including ICD 9 crosswalks / GEMS, chapter information, and DRGs where available.
| ICD 10 CM Field |
Value |
| Diagnosis Code: |
T45.1
|
| Description: |
Poisoning by, adverse effect of and underdosing of antineoplastic and immunosuppressive drugs
-
Excludes1: poisoning by, adverse effect of and underdosing of tamoxifen (T38.6)
|
|
|
| Chapter |
Injury, poisoning and certain other consequences of external causes (S00-T88) |
| Block |
Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances (T36-T50) |
| Parent |
T45 - Poisoning by, adverse effect of and underdosing of primarily systemic and hematological agents, not elsewhere classified |
| ICD-10-CM Children (deeper level / typically more specific) of T45.1: |
|---|
| T45.1X - Poisoning by, adverse effect of and underdosing of antineoplastic and immunosuppressive drugs |
| ICD-10-CM Siblings (same level / similar specificity) of T45.1: |
|---|
| T45.0 - Poisoning by, adverse effect of and underdosing of antiallergic and antiemetic drugs |
| T45.2 - Poisoning by, adverse effect of and underdosing of vitamins |
| T45.3 - Poisoning by, adverse effect of and underdosing of enzymes |
| T45.4 - Poisoning by, adverse effect of and underdosing of iron and its compounds |
| T45.5 - Poisoning by, adverse effect of and underdosing of anticoagulants and antithrombotic drugs |
| T45.6 - Poisoning by, adverse effect of and underdosing of fibrinolysis-affecting drugs |
| T45.7 - Poisoning by, adverse effect of and underdosing of anticoagulant antagonists, vitamin K and other coagulants |
| T45.8 - Poisoning by, adverse effect of and underdosing of other primarily systemic and hematological agents |
| T45.9 - Poisoning by, adverse effect of and underdosing of unspecified primarily systemic and hematological agent |
